News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
KING THOMAS BRAXTON
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| KING THOMAS BRAXTON (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.|
Txns:
| Granted 23,250 options to buy
@ $5.97, valued at
$138.8k
|
|
| 06/08/2023 |
4
| KING THOMAS BRAXTON (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 10,000 options to buy
@ $26.99, valued at
$269.9k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
Disposed/sold 14,893 options to buy
@ $4.56, valued at
$67.9k
Disposed/sold 12,765 options to buy
@ $1.04, valued at
$13.3k
Disposed/sold 12,765 options to buy
@ $0.9, valued at
$11.5k
|
|
| 06/07/2022 |
4
| KING THOMAS BRAXTON (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.46, valued at
$103.8k
|
|
| 12/07/2020 |
4
| KING THOMAS BRAXTON (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.6, valued at
$92k
|
|
| 06/16/2020 |
4
| KING THOMAS BRAXTON (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $26.99, valued at
$269.9k
|
|
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/29/2018 |
4
| KING THOMAS BRAXTON (Director) has filed a Form 4 on VIVUS INC|
Txns:
| Granted 15,000 options to buy
@ $3.53, valued at
$53k
|
|
| 06/19/2018 |
4
| KING THOMAS BRAXTON (Director) has filed a Form 4 on VIVUS INC|
Txns:
| Granted 200,000 options to buy
@ $0.84, valued at
$168k
|
|
| 01/30/2018 |
4
| KING THOMAS BRAXTON (Interim Chief Executive Office) has filed a Form 4 on VIVUS INC|
Txns:
| Granted 600,000 options to buy
@ $0.46, valued at
$276k
|
|
| 07/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2015 |
4
| KING THOMAS BRAXTON (President & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 07/24/2015 |
4
| KING THOMAS BRAXTON (President and CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 400,000 options to buy
@ $1.08, valued at
$432k
|
|
| 05/04/2015 |
4
| KING THOMAS BRAXTON (President and CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 11/03/2014 |
4
| KING THOMAS BRAXTON (President and CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 06/30/2014 |
4
| KING THOMAS BRAXTON (President and CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 100,000 options to buy
@ $4.57, valued at
$457k
|
|
| 05/01/2014 |
4
| KING THOMAS BRAXTON (President and CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 11/04/2013 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 07/30/2013 |
4/A
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Bought 25,000 shares
@ $4.476, valued at
$111.9k
Bought 12,580 shares
@ $4.498, valued at
$56.6k
Bought 2,420 shares
@ $4.49, valued at
$10.9k
|
|
| 07/26/2013 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Bought 25,000 shares
@ $4.476, valued at
$111.9k
Bought 12,580 shares
@ $4.498, valued at
$56.6k
Bought 2,420 shares
@ $4.49, valued at
$10.9k
|
|
| 05/01/2013 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 04/02/2013 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 175,000 shares
@ $4.42, valued at
$773.5k
Granted 350,000 options to buy
@ $4.42, valued at
$1.5M
|
|
| 02/27/2013 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Gifted 9,113 shares
@ $0
Gifted 9,113 shares
@ $0 |
|
| 11/01/2012 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 08/29/2012 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Sold 10,000 shares
@ $4.1364, valued at
$41.4k
Gifted 1,116 shares
@ $0
Gifted 1,116 shares
@ $0 |
|
| 07/30/2012 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.47, valued at
$173.5k
|
|
| 06/08/2012 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Sold 65,516 shares
@ $0.3381, valued at
$22.2k
|
|
| 05/14/2012 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 05/14/2012 |
4/A
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 05/01/2012 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 03/26/2012 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 65,516 shares
@ $0 |
|
| 08/01/2011 |
4
| KING THOMAS BRAXTON (Pres & CEO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 450,000 options to buy
@ $1.53, valued at
$688.5k
|
|
|
|
|